Federated Hermes’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
24,284
-51,061
| -68% | -$2.49M | ﹤0.01% | 1086 |
|
|
2025
Q1 | $3.84M | Buy |
75,345
+27,517
| +58% | +$1.4M | 0.01% | 777 |
|
|
2024
Q4 | $2.16M | Buy |
+47,828
| New | +$2.16M | ﹤0.01% | 912 |
|
|
2023
Q3 | – | Sell |
-732
| Closed | -$29.8K | – | 2180 |
|
|
2023
Q2 | $29.8K | Sell |
732
-7,265
| -91% | -$295K | ﹤0.01% | 1741 |
|
|
2023
Q1 | $387K | Buy |
+7,997
| New | +$387K | ﹤0.01% | 1464 |
|
|
2022
Q4 | – | Sell |
-72,477
| Closed | -$3.64M | – | 2251 |
|
|
2022
Q3 | $3.64M | Buy |
+72,477
| New | +$3.64M | 0.01% | 744 |
|
|
2021
Q2 | – | Sell |
-22
| Closed | -$1K | – | 2306 |
|
|
2021
Q1 | $1K | Sell |
22
-45,397
| -100% | -$2.06M | ﹤0.01% | 2184 |
|
|
2020
Q4 | $2.77M | Buy |
+45,419
| New | +$2.77M | 0.01% | 962 |
|
|
2020
Q2 | – | Sell |
-1,223
| Closed | -$55K | – | 2345 |
|
|
2020
Q1 | $55K | Sell |
1,223
-443,580
| -100% | -$19.9M | ﹤0.01% | 1701 |
|
|
2019
Q4 | $21.4M | Buy |
444,803
+433,141
| +3,714% | +$20.8M | 0.05% | 399 |
|
|
2019
Q3 | $394K | Buy |
+11,662
| New | +$394K | ﹤0.01% | 1485 |
|
|
2018
Q2 | – | Sell |
-29,457
| Closed | -$797K | – | 2267 |
|
|
2018
Q1 | $797K | Buy |
29,457
+28,452
| +2,831% | +$770K | ﹤0.01% | 1284 |
|
|
2017
Q4 | $17K | Sell |
1,005
-1,546
| -61% | -$26.2K | ﹤0.01% | 1796 |
|
|
2017
Q3 | $51K | Sell |
2,551
-1,534
| -38% | -$30.7K | ﹤0.01% | 1640 |
|
|
2017
Q2 | $75K | Sell |
4,085
-1,426
| -26% | -$26.2K | ﹤0.01% | 1608 |
|
|
2017
Q1 | $54K | Buy |
5,511
+4,538
| +466% | +$44.5K | ﹤0.01% | 1608 |
|
|
2016
Q4 | $11K | Buy |
973
+948
| +3,792% | +$10.7K | ﹤0.01% | 1816 |
|
|
2016
Q3 | $1K | Sell |
25
-16,843
| -100% | -$674K | ﹤0.01% | 2075 |
|
|
2016
Q2 | $118K | Buy |
+16,868
| New | +$118K | ﹤0.01% | 1547 |
|